Esophageal Cancer
Oncology·MeSH: Uterine Neoplasms
Prevalence
13.9 / 100K
Incidence
8.0 / 100K/yr
9 drugs in development·8 companies·42 clinical trials
Drug Pipeline by Phase
Phase 3(5)
Phase 1(2)
Preclinical(1)
| Drug | Company |
|---|---|
| esopredict | Castle Biosciences Inc. (CSTL) |
Early Phase 1(1)
| Drug | Company |
|---|---|
| VTP-600 | Barinthus Biotherapeutics plc. (BRNS) |
Compare drugs
Frequently asked questions
How many drugs are in development for Esophageal Cancer?
BioSniper tracks 9 drugs in development for Esophageal Cancer across 8 companies.
How many clinical trials target Esophageal Cancer?
There are 42 clinical trials targeting Esophageal Cancer tracked by BioSniper.
What is the prevalence of Esophageal Cancer?
The estimated prevalence of Esophageal Cancer is approximately 13.9 per 100,000 population.
Deep-dive into Esophageal Cancer
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis